TABLE 1.
Inhibitora | Mean activityb (AFU · min−1 · 25 μl of serum−1) ± SD
|
|
---|---|---|
Uninfected | Infected | |
None | 220 ± 28 | 2,247 ± 88 |
E-64 (10 μM) | 188 ± 17 | 2,355 ± 109 |
Soybean trypsin inhibitor (100 μg · ml−1) | 169 ± 21 | 2,219 ± 199 |
Turkey ovomucoid (100 μg · ml−1) | 166 ± 12 | 2,303 ± 202 |
AEBSF (1 mM) | 145 ± 12 | 166 ± 7 |
3,4-Dichloroisocoumarin (1 mM) | 161 ± 11 | 154 ± 9 |
Inhibitor concentrations reflect the concentrations required for maximum inhibition of Cbz-Arg-Arg-AMC-hydrolytic activity in the sample. Increasing the inhibitor concentrations by up to double those reported here did not increase the degree of inhibition observed.
Trypanosome-free plasma from acutely infected rats and plasma from healthy rats was assayed for activity against Cbz-Arg-Arg-AMC (5 μM) in 50 mM Tris-HCl–1 mM DTT, pH 8, at 37°C.